D Pharm Fundamental Relationships

DPRM -- Israel Stock  

ILS 430.00  0.60  0.00%

The Drivers Module shows relationships between D Pharm's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of D Pharm LTD over time as well as its relative position and ranking within its peers. Additionally see Investing Opportunities.

D Pharm LTD Return On Equity vs. Current Asset Fundamental Analysis

D Pharm LTD is rated below average in current asset category among related companies. It is rated below average in return on equity category among related companies .
Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
D Pharm 
Current Asset 
Liquid Assets 
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.
D Pharm 
Return on Equity 
Net Income 
Total Equity 
For most industries Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

D Pharm LTD Return On Equity Comparison

D Pharm is currently under evaluation in return on equity category among related companies.
Search macroaxis.com